Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study
Introduction The use of monitored anaesthesia care (MAC) is necessary and ubiquitous for fiberoptic bronchoscopy. Anaesthetic management of patients with severe tracheal stenosis has always been a challenge. The efficacy and safety of the MAC with sufentanil target controlled infusion (TCI) and remi...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/8/e058662.full |
| _version_ | 1828112780458196992 |
|---|---|
| author | Yi Zhou Wei Wu Yuanjie Zhu Jianming Liu |
| author_facet | Yi Zhou Wei Wu Yuanjie Zhu Jianming Liu |
| author_sort | Yi Zhou |
| collection | DOAJ |
| description | Introduction The use of monitored anaesthesia care (MAC) is necessary and ubiquitous for fiberoptic bronchoscopy. Anaesthetic management of patients with severe tracheal stenosis has always been a challenge. The efficacy and safety of the MAC with sufentanil target controlled infusion (TCI) and remifentanil TCI in patients with severe tracheal stenosis are still unknown.Methods analysis This study is a prospective, investigator-initiated, two-arm, randomised control trial to compare the efficacy and safety of sufentanil TCI with remifentanil TCI in patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy. 270 patients will be randomly assigned to the sufentanil TCI group or remifentanil TCI group, with a 1:1 ratio in two groups. The primary outcome is the incidence of hypoxaemia (an oxygen saturation of <90%). The secondary outcome investigates the severity of hypoxaemia, cough severity, haemodynamic variables, sedation scores and satisfaction scores.Ethics and dissemination The study has been approved by the Medical Ethics Committee of Shanghai Pulmonary Hospital (approval No. K19-122). The results will be submitted for publication in peer-reviewed journals.Trial registration number ChiCTR2100043380. |
| first_indexed | 2024-04-11T11:55:53Z |
| format | Article |
| id | doaj.art-f776959235484817b76d5787e256e449 |
| institution | Directory Open Access Journal |
| issn | 2044-6055 |
| language | English |
| last_indexed | 2024-04-11T11:55:53Z |
| publishDate | 2022-08-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj.art-f776959235484817b76d5787e256e4492022-12-22T04:25:10ZengBMJ Publishing GroupBMJ Open2044-60552022-08-0112810.1136/bmjopen-2021-058662Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled studyYi Zhou0Wei Wu1Yuanjie Zhu2Jianming Liu3School of Life Sciences and Technology, Tongji University, Shanghai, ChinaDepartment of Anaesthesiology, Shanghai Pulmonary Hospital, School of Medicine,Tongji University, Shanghai, ChinaDepartment of Anaesthesiology, Shanghai Pulmonary Hospital, School of Medicine,Tongji University, Shanghai, ChinaDepartment of Anaesthesiology, Shanghai Pulmonary Hospital, School of Medicine,Tongji University, Shanghai, ChinaIntroduction The use of monitored anaesthesia care (MAC) is necessary and ubiquitous for fiberoptic bronchoscopy. Anaesthetic management of patients with severe tracheal stenosis has always been a challenge. The efficacy and safety of the MAC with sufentanil target controlled infusion (TCI) and remifentanil TCI in patients with severe tracheal stenosis are still unknown.Methods analysis This study is a prospective, investigator-initiated, two-arm, randomised control trial to compare the efficacy and safety of sufentanil TCI with remifentanil TCI in patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy. 270 patients will be randomly assigned to the sufentanil TCI group or remifentanil TCI group, with a 1:1 ratio in two groups. The primary outcome is the incidence of hypoxaemia (an oxygen saturation of <90%). The secondary outcome investigates the severity of hypoxaemia, cough severity, haemodynamic variables, sedation scores and satisfaction scores.Ethics and dissemination The study has been approved by the Medical Ethics Committee of Shanghai Pulmonary Hospital (approval No. K19-122). The results will be submitted for publication in peer-reviewed journals.Trial registration number ChiCTR2100043380.https://bmjopen.bmj.com/content/12/8/e058662.full |
| spellingShingle | Yi Zhou Wei Wu Yuanjie Zhu Jianming Liu Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study BMJ Open |
| title | Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study |
| title_full | Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study |
| title_fullStr | Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study |
| title_full_unstemmed | Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study |
| title_short | Sufentanil target controlled infusion (TCI) versus remifentanil TCI for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy: protocol for a prospective, randomised, controlled study |
| title_sort | sufentanil target controlled infusion tci versus remifentanil tci for monitored anaesthesia care for patients with severe tracheal stenosis undergoing fiberoptic bronchoscopy protocol for a prospective randomised controlled study |
| url | https://bmjopen.bmj.com/content/12/8/e058662.full |
| work_keys_str_mv | AT yizhou sufentaniltargetcontrolledinfusiontciversusremifentaniltciformonitoredanaesthesiacareforpatientswithseveretrachealstenosisundergoingfiberopticbronchoscopyprotocolforaprospectiverandomisedcontrolledstudy AT weiwu sufentaniltargetcontrolledinfusiontciversusremifentaniltciformonitoredanaesthesiacareforpatientswithseveretrachealstenosisundergoingfiberopticbronchoscopyprotocolforaprospectiverandomisedcontrolledstudy AT yuanjiezhu sufentaniltargetcontrolledinfusiontciversusremifentaniltciformonitoredanaesthesiacareforpatientswithseveretrachealstenosisundergoingfiberopticbronchoscopyprotocolforaprospectiverandomisedcontrolledstudy AT jianmingliu sufentaniltargetcontrolledinfusiontciversusremifentaniltciformonitoredanaesthesiacareforpatientswithseveretrachealstenosisundergoingfiberopticbronchoscopyprotocolforaprospectiverandomisedcontrolledstudy |